primary mediastinal large B-cell lymphoma
GPTKB entity
Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
leukemia |
| gptkbp:affects |
gptkb:mediastinum
lymphatic system |
| gptkbp:cellOrigin |
gptkb:B_cell
|
| gptkbp:firstDescribed |
1980s
|
| https://www.w3.org/2000/01/rdf-schema#label |
primary mediastinal large B-cell lymphoma
|
| gptkbp:ICD-10_code |
C85.2
|
| gptkbp:marking |
gptkb:CD20
gptkb:CD30 gptkb:CD23 |
| gptkbp:MeSH_ID |
D054556
|
| gptkbp:OMIM |
609296
|
| gptkbp:prognosis |
generally favorable with treatment
|
| gptkbp:sexPredilection |
female
|
| gptkbp:subclassOf |
diffuse large B-cell lymphoma
|
| gptkbp:symptom |
gptkb:superior_vena_cava_syndrome
cough dyspnea chest mass |
| gptkbp:synonym |
gptkb:PMBCL
gptkb:primary_mediastinal_B-cell_lymphoma gptkb:primary_mediastinal_B-lymphoma |
| gptkbp:treatment |
radiation therapy
chemotherapy immunotherapy |
| gptkbp:typicalAgeOfOnset |
young adults
|
| gptkbp:bfsParent |
gptkb:Keytruda
|
| gptkbp:bfsLayer |
5
|